Sporotrichosis in Children: Case series and Narrative Review

Flavio Queiroz-Telles1, Alexandro Bonifaz2, Regielly Cognialli3,4

  • 1Department of Public Health, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.

Insights

Pediatric sporotrichosis differs between Mexico and Brazil. Mexico sees cases from Sporothrix schenckii, while Brazil faces outbreaks from Sporothrix brasiliensis via cats, requiring different treatments.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pediatrics

Background:

  • Sporotrichosis in children is understudied, with increasing cases linked to environmental changes and pathogen biodiversity.
  • Zoonotic transmission, particularly by *Sporothrix brasiliensis*, is a growing concern in endemic regions like Brazil.

Purpose of the Study:

  • To evaluate risk and prognostic factors for pediatric sporotrichosis.
  • To investigate causes for increased pediatric cases, including environmental factors and pathogen characteristics.
  • To assess the progression of zoonotic transmission of *Sporothrix brasiliensis* infections.

Main Methods:

  • Review of a case series involving 40 pediatric patients.
  • Comparative analysis of clinical manifestations, etiologic agents, and transmission routes in Mexico and Brazil.

Main Results:

  • In Mexico, *Sporothrix schenckii* causes most cases, primarily sapronotically transmitted in rural areas. In Brazil, *Sporothrix brasiliensis* drives a large outbreak linked to cats, with urban prevalence.
  • *S. schenckii* and *S. brasiliensis* present distinct clinical patterns in children, with Mexican patients often showing upper limb involvement and Brazilian patients facial/ocular lesions.
  • Potassium iodide is effective in Mexico, while itraconazole is used in Brazil; faster remission was noted with potassium iodide in Mexico, though further studies are needed.

Conclusions:

  • Distinct etiologic agents (*S. schenckii* vs. *S. brasiliensis*) and transmission patterns (sapronotic vs. zoonotic) characterize pediatric sporotrichosis in Mexico and Brazil.
  • Clinical presentations and treatment responses vary significantly between the two countries, highlighting the need for tailored therapeutic approaches.
  • Further comparative studies are essential to determine the optimal and safest antifungal therapy for pediatric sporotrichosis globally.
Abstract